ETX2514 is a broad-spectrum beta-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii.
Durand-Reville, T.F., Guler, S., Comita-Prevoir, J., Chen, B., Bifulco, N., Huynh, H., Lahiri, S., Shapiro, A.B., McLeod, S.M., Carter, N.M., Moussa, S.H., Velez-Vega, C., Olivier, N.B., McLaughlin, R., Gao, N., Thresher, J., Palmer, T., Andrews, B., Giacobbe, R.A., Newman, J.V., Ehmann, D.E., de Jonge, B., O'Donnell, J., Mueller, J.P., Tommasi, R.A., Miller, A.A.
Nat Microbiol
